Literature DB >> 10663424

Human interferon-alpha increases immobility in the forced swimming test in rats.

M Makino1, Y Kitano, C Komiyama, K Takasuna.   

Abstract

OBJECTIVES: We examined the immobility of the forced swimming test induced in an animal model by human interferon (IFN), which has often been reported to induce depression in clinical use.
METHODS: In the present study, we examined the effects of human IFNs on results of the forced swimming test in rats.
RESULTS: Single intravenous (IV) administration of human IFN-alpha (6x10(4) IU/kg), but not of human IFN-beta or -gamma, significantly increased immobility time in the forced swimming test in rats. Repeated administration of human IFN-alpha (6x10(3) IU/kg) also significantly increased the immobility time. On the other hand, none of the rat IFNs (rat IFN-alpha, -beta and -gamma, 6x10(4) IU/kg, IV) changed the immobility time. Neither human IFNs nor rat IFNs changed the locomotor activity of rats.
CONCLUSIONS: These findings suggest that human IFN-alpha has a greater potential for inducing increase of the immobility in the rat forced swimming test than human IFN-beta and -gamma, and that the effect of human IFN-alpha might not be mediated through IFN-alpha/beta receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663424     DOI: 10.1007/s002130050031

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Assessment of depression in a rodent model of spinal cord injury.

Authors:  Kelsey Luedtke; Sioui Maldonado Bouchard; Sarah A Woller; Mary Katherine Funk; Miriam Aceves; Michelle A Hook
Journal:  J Neurotrauma       Date:  2014-05-08       Impact factor: 5.269

Review 2.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

Review 3.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

4.  Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.

Authors:  M Makino; Y Kitano; C Komiyama; M Hirohashi; K Takasuna
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  Behavioral evaluation of transgenic mice with CNS expression of IFN-alpha by elevated plus-maze and Porsolt swim test.

Authors:  Hua Zhang; Zhanzhuang Tian; Jianping Wang
Journal:  Neurosci Lett       Date:  2010-06-04       Impact factor: 3.046

6.  Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior.

Authors:  François Frenois; Maïté Moreau; Jason O'Connor; Marc Lawson; Charlotte Micon; Jacques Lestage; Keith W Kelley; Robert Dantzer; Nathalie Castanon
Journal:  Psychoneuroendocrinology       Date:  2007-05-04       Impact factor: 4.905

7.  Decreased immobility in swimming test by homologous interferon-alpha in mice accompanied with increased cerebral tryptophan level and serotonin turnover.

Authors:  Jianping Wang; Adrian J Dunn; Amanda J Roberts; Hua Zhang
Journal:  Neurosci Lett       Date:  2009-01-24       Impact factor: 3.046

8.  Interferon-alpha causes neuronal dysfunction in encephalitis.

Authors:  Andrew R Sas; Heather Bimonte-Nelson; C Thetford Smothers; John Woodward; William R Tyor
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

Review 9.  Neuropsychiatric disorders related to interferon and interleukins treatment.

Authors:  Aye Mu Myint; Markus J Schwarz; Harry W M Steinbusch; Brian E Leonard
Journal:  Metab Brain Dis       Date:  2008-12-10       Impact factor: 3.584

10.  Major depression during interferon-alpha treatment: vulnerability and prevention.

Authors:  Francis E Lotrich
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.